RxDoctor Payments Data

Wesley Turner, DO

Family Medicine · Archdale, NCNPI 1013326834

Payments from drug & device makers

$695in general payments, 2019–2025

Across 61 payments — averaging $11.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$142
  • Novo Nordisk$113
  • Takeda Pharmaceuticals U.S.A., Inc.$62
  • Novartis$54
  • Merck$50
  • Astellas Pharma US Inc$41
  • plus $234 from 12 others

What the payments were for

  • Food & beverage$67998%
  • Education$172%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$695 in reported general payments places this provider in the 60th percentile of 3,444 family medicine providers in North Carolina.

See all family medicine providers in North Carolina

Medicare billing

Part B allowed, 2024
$41,123
Medicare patients
128
Services billed
633

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide68$88,476
EliquisApixaban86$74,568
JardianceEmpagliflozin54$49,574
JanuviaSitagliptin Phosphate41$40,114
TrulicityDulaglutide33$34,683
XareltoRivaroxaban29$33,674
Trelegy ElliptaFluticasone/Umeclidin/Vilanter38$29,011
FarxigaDapagliflozin Propanediol35$28,823
Breo ElliptaFluticasone/Vilanterol60$25,411
MounjaroTirzepatide23$24,199
Spiriva RespimatTiotropium Bromide36$20,913
SymbicortBudesonide/Formoterol Fumarate67$19,344
Breztri AerosphereBudesonide/Glycopyr/Formoterol19$14,413
JanumetSitagliptin Phos/Metformin Hcl18$12,194
Repatha SureclickEvolocumab15$10,487

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$113$88,47668 claims
PfizerEliquis$28$74,56886 claims
Boehringer IngelheimJardiance, Spiriva Respimat$11$70,48790 claims
Lilly USA, LLCTrulicity, Mounjaro$38$58,88256 claims
GSKTrelegy Ellipta, Breo Ellipta, Arnuity Ellipta$142$57,059111 claims
MerckJanuvia, Janumet$50$52,30859 claims
Johnson & JohnsonXarelto$26$33,67429 claims
AbbVieLinzess, Synthroid$12$8,52733 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$62$5,78312 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 3,444 family medicine providers in North Carolina.

Other family medicine in Archdale

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →